Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
heart disease
Biotech
Edgewise data power rival to BMS and Cytokinetics toward phase 3
The data keep the biotech on track to start pivotal development of a would-be challenger to Bristol Myers Squibb and Cytokinetics.
Nick Paul Taylor
Jun 16, 2026 10:39am
Kardigan itching for IPO to fund late-stage cardio pipeline
May 27, 2026 4:57am
Blood-based approach could detect early heart, kidney disease
May 12, 2026 7:00am
Artivion nabs clearance from FDA for aortic stent graft system
Apr 8, 2026 7:39am
Kardigan CEO knits trials, digital health into cardio strategy
Jan 28, 2026 10:00am
NIH loses another leader as heart, lung and blood director exits
Jan 13, 2026 4:00am
